Dr Marc D Haber, MD | |
47 New Scotland Ave, Radiology Dept, Albany, NY 12208-3412 | |
(518) 262-3277 | |
(518) 262-4210 |
Full Name | Dr Marc D Haber |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 24 Years |
Location | 47 New Scotland Ave, Albany, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053307587 | NPI | - | NPPES |
03872277 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 221303 (Massachusetts) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 274060 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Francis Hospital & Medical Center | Hartford, CT | Hospital |
Johnson Memorial Hospital | Stafford springs, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology Associates Of Hartford Pllc | 6002703246 | 27 |
Rocky Hill Imaging Center Llc | 5698163160 | 22 |
Radiology Associates Of Hartford Pllc | 6002703246 | 27 |
Rocky Hill Imaging Center Llc | 5698163160 | 22 |
News Archive
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma - a cancer of immature nerve cells - treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
Metabolic signatures in the blood of children with autism spectrum disorder may lead to earlier diagnosis of the condition for some children, according to newly published research. These biochemical signatures provide insight into how the body metabolizes certain amino acids important to typical neurodevelopment.
More blood thinners aren't automatically better, another study confirms. A new publication in JAMA Internal Medicine focuses on the minimal pros and the concerning cons of combining a daily aspirin with a drug from the newer class of anticoagulants that include apixaban, dabigatran, edoxaban and rivaroxaban.
Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).
› Verified 1 days ago
Entity Name | Radiology Associates Of Hartford Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942234893 PECOS PAC ID: 6002703246 Enrollment ID: O20200831000970 |
News Archive
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma - a cancer of immature nerve cells - treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
Metabolic signatures in the blood of children with autism spectrum disorder may lead to earlier diagnosis of the condition for some children, according to newly published research. These biochemical signatures provide insight into how the body metabolizes certain amino acids important to typical neurodevelopment.
More blood thinners aren't automatically better, another study confirms. A new publication in JAMA Internal Medicine focuses on the minimal pros and the concerning cons of combining a daily aspirin with a drug from the newer class of anticoagulants that include apixaban, dabigatran, edoxaban and rivaroxaban.
Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).
› Verified 1 days ago
Entity Name | Rocky Hill Imaging Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184291023 PECOS PAC ID: 5698163160 Enrollment ID: O20211216000497 |
News Archive
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma - a cancer of immature nerve cells - treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
Metabolic signatures in the blood of children with autism spectrum disorder may lead to earlier diagnosis of the condition for some children, according to newly published research. These biochemical signatures provide insight into how the body metabolizes certain amino acids important to typical neurodevelopment.
More blood thinners aren't automatically better, another study confirms. A new publication in JAMA Internal Medicine focuses on the minimal pros and the concerning cons of combining a daily aspirin with a drug from the newer class of anticoagulants that include apixaban, dabigatran, edoxaban and rivaroxaban.
Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Marc D Haber, MD 711 Troy Schenectady Rd, Suite 203, Latham, NY 12110-2442 Ph: (518) 782-3700 | Dr Marc D Haber, MD 47 New Scotland Ave, Radiology Dept, Albany, NY 12208-3412 Ph: (518) 262-3277 |
News Archive
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma - a cancer of immature nerve cells - treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on.
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
Metabolic signatures in the blood of children with autism spectrum disorder may lead to earlier diagnosis of the condition for some children, according to newly published research. These biochemical signatures provide insight into how the body metabolizes certain amino acids important to typical neurodevelopment.
More blood thinners aren't automatically better, another study confirms. A new publication in JAMA Internal Medicine focuses on the minimal pros and the concerning cons of combining a daily aspirin with a drug from the newer class of anticoagulants that include apixaban, dabigatran, edoxaban and rivaroxaban.
Ortho-McNeil, Inc. has announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET (tramadol/acetaminophen).
› Verified 1 days ago
Robert A Belgam, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Stratton Va Medical Center, Albany, NY 12208 Phone: 518-626-6650 Fax: 518-626-6644 | |
Mr. Sreenivas Garla, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Radiology Dept, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
David Jahangir, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Dr. S Rao Aravapalli, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Dept. Of Radiology, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
Sean Peter Roddy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, NY 12208 Phone: 518-262-5640 Fax: 518-262-9413 | |
Dena Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Matthew Robert Shalvoy, MD Radiology Medicare: Medicare Enrolled Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 Fax: 518-525-1200 |